Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px
Document › Details

Bruker Corporation. (8/23/24). "Press Release: Bruker Corporation to Present at Upcoming Investor Conferences". Billerica, MA.

Region Region Boston, MA
  Country United States (USA)
Organisation Organisation Bruker Corporation (Nasdaq: BRKR)
  Group Bruker (Group)
Products Product Wells Fargo Healthcare Conference 2024 Boston
  Product 2 Morgan Stanley Global Healthcare Conference 2024 New York
Index terms Index term Bruker–Wells Fargo: investor conference, 202409 supply service Bruker presents at Wells Fargo Healthcare Conference in Boston
  Index term 2 Bruker–Morgan Stanley: investor conference, 202409 supply service Bruker presents at Morgan Stanley Global Healthcare Conference NY
Persons Person Herman, Gerald N. (Bruker Corp 201806– CFO before Interim CFO joined 12/16 as VP + Corp Controller before Parexel)
  Person 2 Kostka, Joe (Bruker 202408 Associate Director Invesor Relations)
     


Bruker Corporation (Nasdaq: BRKR) announced today that Gerald Herman, Executive Vice President & CFO will present on behalf of the Company at the following investor conferences:

2024 Wells Fargo Healthcare Conference in Boston, MA
Wednesday, September 4, 2024, at 10:15 a.m. Eastern Time

Morgan Stanley 22nd Annual Global Healthcare Conference in New York City
Friday, September 6, 2024, at 10:00 a.m. Eastern Time

Live audiovisual webcasts of the presentations will be available on the Investor Relations section of the Company's website at https://ir.bruker.com . Replays of the presentations will be posted in the “Events & Presentations” section of the Bruker Corporation Investor Relations website after the events and will be available for 90 days following the presentations.


About Bruker Corporation – Leader of the Post-Genomic Era (Nasdaq: BRKR)

Bruker is enabling scientists and engineers to make breakthrough post-genomic discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular, and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research, in applied and biopharma applications, in microscopy and nanoanalysis, as well as in industrial and cleantech research, and next-gen semiconductor metrology in support of AI. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit www.bruker.com .


Joe Kostka
Associate Director, Investor Relations
Bruker Corporation
T: +1 (978) 313-5800
E: Investor.Relations@bruker.com

   
Record changed: 2024-09-26

Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

More documents for Bruker (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x200px




» top